Last checked at 8 Nov 2018 12:43
RNS Number : 8075G
GlaxoSmithKline PLC
08 November 2018
GlaxoSmithKline plc
Director Declaration
In conformity with Listing Rule 9.6.14, GlaxoSmithKline plc (the 'Company') hereby notifies the market that Dr Jesse Goodman, a Non-Executive Director of the Company, has been appointed as a Director to the Board of Intellia Therapeutics, Inc. with effect from 31 October 2018.
V A Whyte
Company Secretary
8 November 2018
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.